Ovarian reserve in young women of reproductive age with Crohn's disease

Inflammatory Bowel Diseases

Volumn 18, Issue 8, 2012, Pages 1515-1522

  Fréour, Thomas ^a   Miossec, Charline ^a   Bach Ngohou, Kalyane ^a   Dejoie, Thomas ^a   Flamant, Mathurin ^a   Maillard, Olivier ^b   Denis, Marc G ^a   Barriere, Paul ^a   Bruley Des Varannes, Stanislas ^a   Bourreille, Arnaud ^a   Masson, Damien ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

anti M llerian hormone; Crohn's disease; inflammatory bowel disease; ovarian reserve

Indexed keywords

AZATHIOPRINE; ESTRADIOL; FOLLITROPIN; INFLIXIMAB; METHOTREXATE; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHILDBIRTH; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROHN DISEASE; DEVELOPMENTAL, AGE AND GROWTH PARAMETERS; DISEASE DURATION; FEMALE; HORMONE DETERMINATION; HUMAN; OVARIAN RESERVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; REPRODUCTIVE AGE; RISK ASSESSMENT;

ADULT; AGE FACTORS; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; OVARY; PREGNANCY; PROGNOSIS; REPRODUCTION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84863982404     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21872     Document Type: Article

References (44)

1. Andres PG, Friedman LS,. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999; 28: 255-281.
2. Mountifield R, Bampton P, Prosser R, et al. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis. 2009; 15: 720-725.
3. Mahadevan U,. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut. 2006; 55: 1198-1206.
4. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007; 56: 830-837.
5. Moscandrew M, Kane S,. Inflammatory bowel diseases and management considerations: fertility and pregnancy. Curr Gastroenterol Rep. 2009; 11: 395-399.
6. Ording Olsen K, Juul S, Berndtsson I, et al. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology. 2002; 122: 15-19.
7. Waljee A, Waljee J, Morris AM, et al. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006; 55: 1575-1580.
8. Mayberry JF, Weterman IT,. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut. 1986; 27: 821-825.
9. Fielding JF, Cooke WT,. Pregnancy and Crohn's disease. Br Med J. 1970; 2: 76-77.
10. Khosla R, Willoughby CP, Jewell DP,. Crohn's disease and pregnancy. Gut. 1984; 25: 52-56.
11. Hudson M, Flett G, Sinclair TS, et al. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet. 1997; 58: 229-237.
12. Baird DD, Narendranathan M, Sandler RS,. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology. 1990; 99: 987-994.
13. Toovey S, Hudson E, Hendry WF, et al. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut. 1981; 22: 445-451.
14. Wolters FL, Russel MG, Sijbrandij J, et al. European Collaborative Study Group On Inflammatory Bowel Disease. Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol. 2006; 243: 46-54.
15. Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2004; 47: 1119-1126.
16. Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006; 12: 685-718.
17. Fanchin R, Schonäuer LM, Righini C, et al. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003; 18: 323-327.
18. La Marca A, Stabile G, Artenisio AC, et al. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006; 21: 3103-3107.
19. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749-753.
20. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19: 41-47.
21. La Marca A, Pati M, Orvieto R, et al. Serum anti-Müllerian hormone levels in women with secondary amenorrhea. Fertil Steril. 2006; 85: 1547-1549.
22. Laven JS, Mulders AG, Visser JA, et al. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004; 89: 318-323.
23. Knauff EA, Eijkemans MJ, Lambalk CB, et al. Dutch premature ovarian failure consortium anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009; 94: 786-792.
24. La Marca A, Sighinolfi G, Giulini S, et al. Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles. Reprod Biomed Online. 2010; 21: 463-469.
25. Marri SR, Ahn C, Buchman AL,. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 591-599.
26. Wallace WH, Kelsey TW,. Human ovarian reserve from conception to the menopause. PLoS One. 2010; 27; 5: e8772.
27. Broekmans FJ, Soules MR, Fauser BC,. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009; 30: 465-493.
28. van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002; 17: 3065-3071.
29. van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005; 83: 979-987.
30. van Disseldorp J, Faddy MJ, Themmen AP, et al. Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab. 2008; 93: 2129-2134.
31. Nardo LG, Gelbaya TA, Wilkinson H, et al. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009; 92: 1586-1593.
32. Gnoth C, Schuring AN, Friol K, et al. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod. 2008; 23: 1359-1365.
33. Broer SL, Mol B, Dõlleman M, et al. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol. 2010; 22: 193-201.
34. van Beek RD, van den Heuvel-Eibrink MM, Laven JS, et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab. 2007; 92: 3869-3874.
35. Decanter C, Morschhauser F, Pigny P, et al. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online. 2010; 20: 280-285.
36. Falconer H, Sundqvist J, Gemzell-Danielsson K, et al. IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone. Reprod Biomed Online. 2009; 18: 582-588.
37. Montagna P, Capellino S, Villaggio B, et al. Peritoneal fluid macrophages in endometriosis: correlation between the expression of estrogen receptors and inflammation. Fertil Steril. 2008; 90: 156-164.
38. Craninx M, D'Haens G, Cokelaere K, et al. Crohn's disease and intestinal endometriosis: an intriguing co-existence. Eur J Gastroenterol Hepatol. 2000; 12: 217-221.
39. Winger E, Reed J, Ashoush S, et al. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol. 2009; 61: 13-20.
40. Hong CY, Park JH, Seo KH, et al. Expression of MIS in the testis is downregulated by tumor necrosis factor alpha through the negative regulation of SF-1 transactivation by NF-kappa B. Mol Cell Biol. 2003; 23: 6000-6012.
41. van der Heide F, Dijkstra A, Weersma RK, et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2009; 15: 1199-1207.
42. Freour T, Masson D, Mirallie S, et al. Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online. 2008; 16: 96-102.
43. Stein SL, Michelassi F,. How can fecundity be preserved in patients undergoing pelvic surgery? Nat Clin Pract Gastroenterol Hepatol. 2008; 5: 308-309.
44. Arkuran C, McComb P,. Crohn's disease and tubal infertility: the effect of adhesion formation. Clin Exp Obstet Gynecol. 2000; 27: 12-13.